Home > Journals > European Journal of Physical and Rehabilitation Medicine > Past Issues > European Journal of Physical and Rehabilitation Medicine 2013 April;49(2) > European Journal of Physical and Rehabilitation Medicine 2013 April;49(2):243-9

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

REVIEWS  UPDATE ON DRUGS IN STROKE REHABILITATION Freefree

European Journal of Physical and Rehabilitation Medicine 2013 April;49(2):243-9

Copyright © 2013 EDIZIONI MINERVA MEDICA

language: English

Role, indications and controversies of levodopa administration in chronic stroke patients

Acler M. 1, 2, Manganotti P. 2

1 Operative Unit of Neurology, S. Chiara Hospital, APSS, Trento, Italy; 2 Unit of Clinical Neurology, Department of Neurological, Neuropsychological, Morphological and Movement Sciences, University of Verona, Verona, Italy


PDF


Stroke leaves many patients disabled even after rehabilitative training, representing a major cause of disability. Several approaches to improve outcomes have been attempted in recent years, with only relative benefit. Emerging evidences show a potential role of pharmacological intervention to enhance motor recovery after stroke. Contrasting evidence are coming from experimental and clinical studies, so far, and pharmacological intervention during rehabilitation represents a major controversial in neurorehabilitation. Dopaminergic stimulation appears as one of the most promising way to improve motor recovery. Subject of this paper will be the ratio underlying the clinical use of levodopa in chronic stroke patients, trying to outline the most convincing evidences about a potential role of this drug in rehabilitative strategies.

top of page